<DOC>
	<DOCNO>NCT00547677</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiosurgery may able send x-ray directly tumor cause less damage normal tissue . PURPOSE : This phase I trial study side effect best dose stereotactic radiosurgery treat patient liver metastasis .</brief_summary>
	<brief_title>Stereotactic Radiosurgery Treating Patients With Liver Metastases</brief_title>
	<detailed_description>OBJECTIVES : - To determine maximum tolerate dose fractionate stereotactic radiosurgery patient hepatic metastasis . - To determine dose-limiting toxicity stereotactic radiosurgery patient . - To assess tumor response patient . OUTLINE : This multicenter study . Patients receive 3-5 fraction stereotactic radiosurgery 14 day absence disease progression unacceptable toxicity . Cohorts 9-13 patient receive escalate dos stereotactic radiosurgery 60 Gy reach maximum tolerated dose ( MTD ) determine . The MTD define dose precede &gt; 33 % patient experience dose-limiting toxicity . After completion study therapy , patient follow 6 week , every 3 month 1 year , every 6 month 2 year , annually 2 year .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary cancer Stage IV primary disease five liver metastasis visualize CT scan , MRI abdomen , positronemission tomography No liver metastases secondary germ cell tumor hematologic malignancy Other sit metastasis allow No malignant ascites The cumulative total dose radiotherapy ≥ 2/3 liver surround normal tissue , include esophagus , stomach , small bowel , must ≤ 15 Gy Percutaneous laparoscopic biopsy metastasis placement 35 fiducials require undergoing Cyberknife treatment delivery PATIENT CHARACTERISTICS : Karnofsky performance status 60100 % Life expectancy ≥ 3 month Albumin ≥ 3 g/dL Alkaline phosphatase &lt; 1.5 time upper limit normal ( ULN ) AST ALT &lt; 1.5 time ULN Total bilirubin &lt; 1.5 time ULN Prothrombin time &lt; 1.5 time ULN Hemoglobin &gt; 10 g/dL Platelet count &gt; 100,000/mm³ ANC &gt; 1,000/mm³ Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No history diagnose inflammatory bowel disease , ulcerative colitis Crohn 's disease No active peptic ulcer disease No hepatorenal syndrome PRIOR CONCURRENT THERAPY : Prior systemic therapy allow provided complete blood cell count recover No concurrent antineoplastic treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>liver metastasis</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>